July 27, 2023 12:29 PM EDTUpdated 12:51 PM
Pharma
FDA+
Manufacturing

As pres­sure mounts to take ac­tion on drug short­ages, law­mak­ers seek to boost pro­duc­tion in the US

Lia DeGroot

A bi­par­ti­san group of sen­a­tors in­tro­duced leg­is­la­tion on Thurs­day that aims to bol­ster do­mes­tic gener­ic man­u­fac­tur­ing in an ef­fort to shore up stock­piles of key …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Ex­clu­sive: Col­or Health alums raise $10M for new start­up, us­ing AI for reg­u­la­to­ry work

A service from the Financial Times